{"count": 8, "results": [{"_id": "30460043", "pmid": 30460043, "pmcid": "PMC6234689", "title": "Ocular kinetics and safety of intravitreally injected angiotensin converting enzyme inhibitor lisinopril", "journal": "Int J Retina Vitreous", "authors": ["Nath M", "Halder N", "Chandra P", "Singh SB", "Deorari AK", "Kumar A", "Velpandian T"], "date": "2018-11-14T00:00:00Z", "doi": "10.1186/s40942-018-0146-7", "meta_date_publication": "2018", "meta_volume": "4", "meta_issue": "", "meta_pages": "42", "score": 50104.824, "text_hl": "The study investigated the intravitreal safety and vitreous disposition of @<m>CHEMICAL_Lisinopril</m> @CHEMICAL_MESH:D017706 @@@lisinopril@@@, an angiotensin converting enzyme inhibitor in @SPECIES_9986 @@@rabbits@@@ for its projected use in @<m>DISEASE_Hypertensive_Retinopathy</m> @DISEASE_MESH:D058437 @@@retinopathy@@@.", "citations": {"NLM": "Nath M, Halder N, Chandra P, Singh SB, Deorari AK, Kumar A, Velpandian T. Ocular kinetics and safety of intravitreally injected angiotensin converting enzyme inhibitor lisinopril Int J Retina Vitreous. 2018;4():42. PMID: 30460043", "BibTeX": "@article{30460043, title={Ocular kinetics and safety of intravitreally injected angiotensin converting enzyme inhibitor lisinopril}, author={Nath M and Halder N and Chandra P and Singh SB and Deorari AK and Kumar A and Velpandian T}, journal={Int J Retina Vitreous}, volume={4}, pages={42}}"}}, {"_id": "10051804", "pmid": 10051804, "title": "[Effect of lisinopril on progression of retinopathy and microalbuminuria in normotensive subjects with insulin-dependent diabetes mellitus].", "journal": "Ugeskr Laeger", "authors": ["Sjølie AK", "Chaturvedi N", "Fuller J"], "date": "1999-02-15T00:00:00Z", "meta_date_publication": "1999 Feb 15", "meta_volume": "161", "meta_issue": "7", "meta_pages": "949-52", "score": 50077.43, "text_hl": "[Effect of @<m>CHEMICAL_Lisinopril</m> @CHEMICAL_MESH:D017706 @@@lisinopril@@@ on progression of @<m>DISEASE_Hypertensive_Retinopathy</m> @DISEASE_MESH:D058437 @@@retinopathy@@@ and microalbuminuria in normotensive subjects with @DISEASE_Diabetes_Mellitus_Type_1 @DISEASE_MESH:D003922 @@@insulin-dependent diabetes mellitus@@@].", "citations": {"NLM": "Sjølie AK, Chaturvedi N, Fuller J. [Effect of lisinopril on progression of retinopathy and microalbuminuria in normotensive subjects with insulin-dependent diabetes mellitus]. Ugeskr Laeger. 1999 Feb 15;161(7):949-52. PMID: 10051804", "BibTeX": "@article{10051804, title={[Effect of lisinopril on progression of retinopathy and microalbuminuria in normotensive subjects with insulin-dependent diabetes mellitus].}, author={Sjølie AK and Chaturvedi N and Fuller J}, journal={Ugeskr Laeger}, volume={161}, number={7}, pages={949-52}}"}}, {"_id": "9433426", "pmid": 9433426, "title": "Effect of lisinopril on progression of retinopathy in normotensive people with type 1 diabetes. The EUCLID Study Group. EURODIAB Controlled Trial of Lisinopril in Insulin-Dependent Diabetes Mellitus.", "journal": "Lancet", "authors": ["Chaturvedi N", "Sjolie AK", "Stephenson JM", "Abrahamian H", "Keipes M", "Castellarin A", "Rogulja-Pepeonik Z", "Fuller JH"], "date": "1998-01-03T00:00:00Z", "doi": "10.1016/s0140-6736(97)06209-0", "meta_date_publication": "1998 Jan 3", "meta_volume": "351", "meta_issue": "9095", "meta_pages": "28-31", "score": 50077.336, "text_hl": "Effect of @<m>CHEMICAL_Lisinopril</m> @CHEMICAL_MESH:D017706 @@@lisinopril@@@ on progression of @<m>DISEASE_Hypertensive_Retinopathy</m> @DISEASE_MESH:D058437 @@@retinopathy@@@ in normotensive people with @DISEASE_Diabetes_Mellitus_Type_1 @DISEASE_MESH:D003922 @@@type 1 diabetes@@@. ", "citations": {"NLM": "Chaturvedi N, Sjolie AK, Stephenson JM, Abrahamian H, Keipes M, Castellarin A, Rogulja-Pepeonik Z, Fuller JH. Effect of lisinopril on progression of retinopathy in normotensive people with type 1 diabetes. The EUCLID Study Group. EURODIAB Controlled Trial of Lisinopril in Insulin-Dependent Diabetes Mellitus. Lancet. 1998 Jan 3;351(9095):28-31. PMID: 9433426", "BibTeX": "@article{9433426, title={Effect of lisinopril on progression of retinopathy in normotensive people with type 1 diabetes. The EUCLID Study Group. EURODIAB Controlled Trial of Lisinopril in Insulin-Dependent Diabetes Mellitus.}, author={Chaturvedi N and Sjolie AK and Stephenson JM and Abrahamian H and Keipes M and Castellarin A and Rogulja-Pepeonik Z and Fuller JH}, journal={Lancet}, volume={351}, number={9095}, pages={28-31}}"}}, {"_id": "9179532", "pmid": 9179532, "title": "Lisinopril. A review of its pharmacology and use in the management of the complications of diabetes mellitus.", "journal": "Drugs", "authors": ["Goa KL", "Haria M", "Wilde MI"], "date": "1997-06-01T00:00:00Z", "doi": "10.2165/00003495-199753060-00010", "meta_date_publication": "1997 Jun", "meta_volume": "53", "meta_issue": "6", "meta_pages": "1081-105", "score": 50071.984, "text_hl": "Progression to @<m>DISEASE_Hypertensive_Retinopathy</m> @DISEASE_MESH:D058437 @@@retinopathy@@@ was slowed during 2 years' @<m>CHEMICAL_Lisinopril</m> @CHEMICAL_MESH:D017706 @@@lisinopril@@@ therapy in the EUCLID study. ", "citations": {"NLM": "Goa KL, Haria M, Wilde MI. Lisinopril. A review of its pharmacology and use in the management of the complications of diabetes mellitus. Drugs. 1997 Jun;53(6):1081-105. PMID: 9179532", "BibTeX": "@article{9179532, title={Lisinopril. A review of its pharmacology and use in the management of the complications of diabetes mellitus.}, author={Goa KL and Haria M and Wilde MI}, journal={Drugs}, volume={53}, number={6}, pages={1081-105}}"}}, {"_id": "21755314", "pmid": 21755314, "title": "Aliskiren reduces vascular pathology in diabetic retinopathy and oxygen-induced retinopathy in the transgenic (mRen-2)27 rat.", "journal": "Diabetologia", "authors": ["Wilkinson-Berka JL", "Tan G", "Binger KJ", "Sutton L", "McMaster K", "Deliyanti D", "Perera G", "Campbell DJ", "Miller AG"], "date": "2011-10-01T00:00:00Z", "doi": "10.1007/s00125-011-2239-9", "meta_date_publication": "2011 Oct", "meta_volume": "54", "meta_issue": "10", "meta_pages": "2724-35", "score": 50065.37, "text_hl": "@CHEMICAL_aliskiren @CHEMICAL_MESH:C446481 @@@Aliskiren@@@ (10 or 30 mg kg(-1) day(-1), pump) or @<m>CHEMICAL_Lisinopril</m> @CHEMICAL_MESH:D017706 @@@lisinopril@@@ (10 mg kg(-1) day(-1), drinking water) was administered during @<m>DISEASE_Hypertensive_Retinopathy</m> @DISEASE_MESH:D058437 @@@retinopathy@@@ development between postnatal days 12 and 18. ", "citations": {"NLM": "Wilkinson-Berka JL, Tan G, Binger KJ, Sutton L, McMaster K, Deliyanti D, Perera G, Campbell DJ, Miller AG. Aliskiren reduces vascular pathology in diabetic retinopathy and oxygen-induced retinopathy in the transgenic (mRen-2)27 rat. Diabetologia. 2011 Oct;54(10):2724-35. PMID: 21755314", "BibTeX": "@article{21755314, title={Aliskiren reduces vascular pathology in diabetic retinopathy and oxygen-induced retinopathy in the transgenic (mRen-2)27 rat.}, author={Wilkinson-Berka JL and Tan G and Binger KJ and Sutton L and McMaster K and Deliyanti D and Perera G and Campbell DJ and Miller AG}, journal={Diabetologia}, volume={54}, number={10}, pages={2724-35}}"}}, {"_id": "19648902", "pmid": 19648902, "title": "Diabetic retinopathy and blockade of the renin-angiotensin system: new data from the DIRECT study programme.", "journal": "Eye (Lond)", "authors": ["Wright AD", "Dodson PM"], "date": "2010-01-01T00:00:00Z", "doi": "10.1038/eye.2009.189", "meta_date_publication": "2010 Jan", "meta_volume": "24", "meta_issue": "1", "meta_pages": "1-6", "score": 50050.523, "text_hl": "This arose from the promising improvement of @<m>DISEASE_Hypertensive_Retinopathy</m> @DISEASE_MESH:D058437 @@@retinopathy@@@ outcomes in the EUCLID study of @<m>CHEMICAL_Lisinopril</m> @CHEMICAL_MESH:D017706 @@@lisinopril@@@ in @DISEASE_Diabetes_Mellitus_Type_1 @DISEASE_MESH:D003922 @@@type I diabetes@@@. ", "citations": {"NLM": "Wright AD, Dodson PM. Diabetic retinopathy and blockade of the renin-angiotensin system: new data from the DIRECT study programme. Eye (Lond). 2010 Jan;24(1):1-6. PMID: 19648902", "BibTeX": "@article{19648902, title={Diabetic retinopathy and blockade of the renin-angiotensin system: new data from the DIRECT study programme.}, author={Wright AD and Dodson PM}, journal={Eye (Lond)}, volume={24}, number={1}, pages={1-6}}"}}, {"_id": "12140727", "pmid": 12140727, "title": "The retinal renin-angiotensin system: implications for therapy in diabetic retinopathy.", "journal": "J Hum Hypertens", "authors": ["Sjølie AK", "Chaturvedi N"], "date": "2002-08-01T00:00:00Z", "doi": "10.1038/sj.jhh.1001438", "meta_date_publication": "2002 Aug", "meta_volume": "16 Suppl 3", "meta_issue": "", "meta_pages": "S42-6", "score": 50048.3, "text_hl": "In the EUCLID Study, the @GENE_ACE @GENE_1636 @@@angiotensin converting enzyme@@@ (@GENE_ACE @GENE_1636 @@@ACE@@@) inhibitor @<m>CHEMICAL_Lisinopril</m> @CHEMICAL_MESH:D017706 @@@lisinopril@@@ reduced the risk of progression of @<m>DISEASE_Hypertensive_Retinopathy</m> @DISEASE_MESH:D058437 @@@retinopathy@@@ by approximately 50%, and also significantly reduced the risk of progression to @DISEASE_603933 @DISEASE_OMIM:603933 @@@proliferative retinopathy@@@. ", "citations": {"NLM": "Sjølie AK, Chaturvedi N. The retinal renin-angiotensin system: implications for therapy in diabetic retinopathy. J Hum Hypertens. 2002 Aug;16 Suppl 3():S42-6. PMID: 12140727", "BibTeX": "@article{12140727, title={The retinal renin-angiotensin system: implications for therapy in diabetic retinopathy.}, author={Sjølie AK and Chaturvedi N}, journal={J Hum Hypertens}, volume={16 Suppl 3}, pages={S42-6}}"}}, {"_id": "16981424", "pmid": 16981424, "title": "[Prevention of target organ damage with modern antihypertensive agents].", "journal": "Orv Hetil", "authors": ["Páll D", "Katona E", "Juhász M", "Paragh G"], "date": "2006-08-13T00:00:00Z", "meta_date_publication": "2006 Aug 13", "meta_volume": "147", "meta_issue": "32", "meta_pages": "1505-11", "score": 50045.816, "text_hl": "There are plenty of evidence which demonstrate that @<m>CHEMICAL_Lisinopril</m> @CHEMICAL_MESH:D017706 @@@lisinopril@@@, a first line antihypertensive agent, has a positive effect in the treatment of @DISEASE_Hypertrophy_Left_Ventricular @DISEASE_MESH:D017379 @@@left ventricular hypertrophy@@@, @<m>DISEASE_Hypertensive_Retinopathy</m> @DISEASE_MESH:D058437 @@@retinopathy@@@ and @DISEASE_Kidney_Diseases @DISEASE_MESH:D007674 @@@nephropathy@@@, and also has a favourable outcome after @DISEASE_Myocardial_Infarction @DISEASE_MESH:D009203 @@@myocardial infarction@@@ and in @DISEASE_Heart_Failure @DISEASE_MESH:D006333 @@@heart failure@@@. ", "citations": {"NLM": "Páll D, Katona E, Juhász M, Paragh G. [Prevention of target organ damage with modern antihypertensive agents]. Orv Hetil. 2006 Aug 13;147(32):1505-11. PMID: 16981424", "BibTeX": "@article{16981424, title={[Prevention of target organ damage with modern antihypertensive agents].}, author={Páll D and Katona E and Juhász M and Paragh G}, journal={Orv Hetil}, volume={147}, number={32}, pages={1505-11}}"}}]}